Fight Aging! Newsletter, January 4th 2021

The objective of this study is to quantify the overall and cancer type-specific risks of subsequent primary cancers (SPCs) among adult-onset cancer survivors by first primary cancer (FPC) types and sex. Among 1,537,101 survivors (mean age, 60.4 years; 48.8% women), 156,442 SPC cases and 88,818 SPC deaths occurred during 11,197,890 person-years of follow-up (mean, 7.3 years). Among men, the overall risk of developing any SPCs was statistically significantly higher for 18 of the 30 FPC types, and risk of dying from any SPCs was statistically significantly higher for 27 of 30 FPC types as compared with risks in the general population. Among women, the overall risk of developing any SPCs was statistically significantly higher for 21 of the 31 FPC types, and risk of dying from any SPCs was statistically significantly higher for 28 of 31 FPC types as compared with risks in the general population. The highest overall standardized incidence ratio (SIR) and standardized mortality ratio (SMR) were estimated among survivors of laryngeal cancer (SIR, 1.75; incidence, 373 per 10,000 person-years) and gallbladder cancer (SMR, 3.82; mortality, 341 per 10,000 person-years) among men, and among survivors of laryngeal cancer (SIR, 2.48; incidence, 336 per 10,000 person-years; SMR, 4.56; mortality, 268 per 10,000 person-years) among women. Substantial variation existed in the associations of specific types of FPCs with specific types of SPC risk; however, only a few smoking- or obesity-a...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
More News: Academia | Age-Related Macular Degeneration (AMD) | Allergy & Immunology | Alopecia | Alzheimer's | Amyloidosis | Aspirin | Atrial Fibrillation | Audiology | Biology | Biotechnology | Bladder Cancer | Blindness | Brain | Brain Cancers | Cancer | Cancer & Oncology | Cancer of the Uterus | Cancer Therapy | Cancer Vaccines | Cardiology | Cardiovascular | Cervical Cancer | Chemistry | Chemotherapy | Cholesterol | Chronic Kidney Disease | Chronic Leukemia | Clinical Trials | Colorectal Cancer | Conferences | COVID-19 | Databases & Libraries | Deafness | Dementia | Diabetes | Diets | Eating Disorders & Weight Management | Education | Emergency Medicine | Endocrinology | Environmental Health | Epidemiology | Epithelial Cancer | Esophagus Cancer | Flu Pandemic | Fortamet | Funding | Fundraising | Gallbladder Cancer | Gastroschisis Repair | Gene Therapy | Genetics | Glaucoma | Glucosamine | Heart | Heart Disease | Heart Failure | Heart Transplant | Hormonal Therapy | Hormones | Hyperbaric Oxygen Therapy | Hypertension | Immunotherapy | Infectious Diseases | Influenza | Influenza Vaccine | Insulin | Kidney Transplant | Kidney Transplantation | Laboratory Medicine | Laryngeal Cancer | Learning | Leukemia | Liver | Liver Transplant | Lung Cancer | Lung Transplant | Metabolic Syndrome | Metformin | Metolazone | Mitochondria | Mitochondrial Disease | Molecular Biology | Nanotechnology | National Institute for Health and Clinical Excelle | Neurology | Neuroscience | Nilotinib | Nutrition | Obesity | Opthalmology | Oral Cancer | Oral Cavity Cancer | Orthopaedics | Osteoarthritis | Osteoporosis | Pancreas | Pancreatic Cancer | Pandemics | Parkinson's Disease | Peripheral Neuropathy | Pharmaceuticals | Pharyngeal Cancer | Politics | Pulmonary Thromboembolism | Reproduction Medicine | Research | SARS | Science | Skin | Smokers | Sports Medicine | Statistics | Stem Cell Therapy | Stem Cells | Stroke | Study | Tasigna | Thrombosis | Toxicology | Training | Transplant Surgery | Transplants | Trimethylamine | Universities & Medical Training | Urology & Nephrology | USA Health | Vaccines | Veterinary Vaccinations | Vitamin A | Vitamin B3 | Wheat | Women